Eon Labs famotidine
This article was originally published in The Tan Sheet
Executive Summary
Firm's application (ANDA 76-101) for generic equivalent to J&J/Merck's Pepcid AC approved by FDA Oct. 21. Eon likely will partner with another company to bring the H2 antagonist to market but has no imminent launch plans. Five other companies hold ANDA approval for 10 mg tablets (1"The Tan Sheet" April 8, 2002, In Brief)...